Every batch of Labrat Peptides undergoes third-party Mass Spectrometry and HPLC analysis. We believe in absolute transparency - since in third-party marketing we need complete confidence.
GLP Tirze 40MG Reta 20MG is a multi-component research peptide blend supplied by Lab Rat Peptides for laboratory research, analytical testing, and scientific investigation. The formulation contains 40MG of GLP Tirze and 20MG of Reta, providing a total listed quantity of 60MG per formulation.
This research material is produced for qualified researchers, laboratories, academic institutions, biotechnology organizations, and other authorized scientific environments conducting controlled research.
The product is supplied strictly for Research Use Only (RUO). It is not intended for human consumption, self-administration, therapeutic use, clinical treatment, veterinary applications, cosmetic use, or diagnostic purposes.
Researchers looking for additional laboratory materials can explore the Research Peptides Collection to find other compounds and peptide formulations available for scientific investigation.
This multi-component formulation contains two individually identified research components:
| Research Component | Listed Amount |
|---|---|
| GLP Tirze | 40MG |
| Reta | 20MG |
| Total Listed Amount | 60MG |
The product name reflects the individual quantities included in the formulation. Researchers should always check the product label and applicable batch documentation when recording material information for laboratory use.
It is also important to distinguish this formulation from products listed under different quantities. For example, a product described as GLP Tirze 20MG may represent a separate product or formulation.
Reliable research depends on consistent and well-documented laboratory materials. Lab Rat Peptides follows controlled production and quality-assurance procedures designed to support consistency, traceability, and product integrity.
Production and quality procedures may include:
Researchers should use the documentation associated with the specific batch received when recording product information or evaluating research materials.
Where available, batch documentation can assist laboratories with inventory management, material identification, analytical review, and internal research records.
The formulation may be evaluated within appropriately designed laboratory studies involving peptide research and related scientific investigations.
Potential areas of research include:
The suitability of a research material depends on the objectives, experimental model, methodology, and laboratory procedures established by the research team.
Researchers conducting literature reviews can use established scientific databases such as PubMed and the National Center for Biotechnology Information (NCBI) to review published research and experimental methodologies.
Published studies should always be evaluated according to their original experimental conditions, research models, methodology, and limitations.
The formulation provides researchers with a convenient multi-component research material containing two separately identified components.
Key features include:
Researchers should verify the exact composition and product documentation before incorporating any material into laboratory protocols.
A Certificate of Analysis (COA) can provide important batch-level information about research materials.
Where applicable, the COA associated with the product may contain analytical information relating to the particular production batch, such as reported identity, purity, and other testing information.
Researchers should retain the relevant documentation with their laboratory records and use batch-specific information when documenting materials.
For additional information, researchers can visit the Lab Rat Peptides COA page to review available analytical documentation.
Because analytical results can be batch-specific, researchers should prioritize the documentation supplied for the actual batch received rather than relying solely on general product descriptions.
Researchers searching for GLP Tirze 20MG may encounter different products or quantities within research peptide catalogs.
The formulation described on this page contains:
40MG GLP Tirze + 20MG Reta
Therefore, the 20MG quantity refers to the Reta component rather than the GLP Tirze component.
When comparing research materials, laboratories should carefully review:
This helps reduce confusion when maintaining laboratory inventories or comparing different research formulations.
Research materials should be stored and handled according to applicable product documentation and established laboratory procedures.
General laboratory considerations include:
Specific storage conditions may depend on the formulation, packaging, and research requirements. Qualified laboratory personnel should consult the applicable documentation before establishing storage procedures.
Any preparation or reconstitution required for an experiment should be determined by qualified laboratory personnel according to validated laboratory protocols and the requirements of the research design.
GLP Tirze 40MG Reta 20MG is available through the Lab Rat Peptides research catalog, subject to current inventory.
Products are packaged for laboratory research and processed through the Lab Rat Peptides ordering system. Researchers should inspect packaging and accompanying documentation when materials are received and follow their institution's procedures for receiving and storing laboratory products.
Product: GLP Tirze 40MG Reta 20MG Research Peptide Blend
Composition: 40MG GLP Tirze + 20MG Reta
Total Listed Amount: 60MG
Product Type: Multi-component research formulation
Use: Research Use Only
Availability: Subject to current inventory
Shipping: Domestic and international options may be available
COA: Batch-specific documentation where applicable
Researchers interested in related laboratory materials can explore the Lab Rat Peptides Research Peptides category.
Additional products may include:
Researchers should review each individual product page and applicable batch documentation before selecting materials for a specific investigation.
Researchers investigating peptide biology, molecular pathways, and related scientific subjects can consult established scientific resources.
PubMed provides access to biomedical and life-science publications maintained by the U.S. National Library of Medicine.
NCBI provides access to scientific databases covering areas such as molecular biology, genetics, biochemistry, and biomedical research.
Researchers may also consult the U.S. Food and Drug Administration (FDA) for applicable regulatory and scientific information.
These external resources provide useful starting points for literature reviews and regulatory research. Published information should always be assessed according to the original study design, experimental conditions, methodology, and limitations.
It is a multi-component research peptide formulation containing 40MG of GLP Tirze and 20MG of Reta, for a total listed formulation amount of 60MG.
The product is supplied exclusively for laboratory research and scientific investigation.
The formulation contains:
Researchers should verify the product label and batch documentation for the material received.
No. GLP Tirze 20MG may refer to a different research product or quantity.
The formulation described here contains 40MG of GLP Tirze and 20MG of Reta. Researchers should verify the exact product specification before ordering or documenting research materials.
The product is intended for qualified laboratory professionals, research institutions, universities, biotechnology organizations, and other authorized scientific environments conducting lawful laboratory research.
Purchasers are responsible for ensuring that their intended use complies with applicable laws, regulations, institutional requirements, and laboratory procedures.
Researchers should follow the storage instructions supplied with the product and their laboratory's established material-handling procedures.
The material should generally be protected from excessive heat, moisture, direct sunlight, and unnecessary environmental exposure.
No. This product is supplied exclusively for laboratory research and scientific investigation.
It is not intended for human consumption, self-administration, therapeutic use, clinical treatment, veterinary use, cosmetic applications, or diagnostic procedures.
GLP Tirze 40MG Reta 20MG is supplied exclusively as Research Use Only (RUO) material.
The product is intended for lawful laboratory and scientific research and is not marketed as a drug, medical treatment, or diagnostic product.
Lab Rat Peptides does not provide medical advice or make therapeutic, clinical, or diagnostic claims regarding this research material or its individual components.
The information presented on this page is provided for research and educational reference purposes. It should not be interpreted as medical advice, clinical guidance, or a recommendation for human application.
Researchers and institutions are responsible for determining whether a research material is appropriate for their intended experimental application and for ensuring compliance with applicable laws, regulations, institutional requirements, laboratory safety procedures, and research protocols.
For the most accurate product information, researchers should review the product label, applicable batch-specific Certificate of Analysis, and documentation supplied with the material.
For additional questions about the product or your order, please Contact Lab Rat Peptides. You can also review the Refund Policy and Shipping Policy for additional information.
| Sequence | Available on COA |
| Appearance | White Lyophilized Powder |
| Mol. Weight | 1419.6 g/mol |
| Purity | 99.2% |
| Storage | -20°C or below |
| SKU | LRP-GLP-Tirze-40MG-Reta -0MG |
All peptides and research chemicals sold on this site are intended exclusively for in-vitro laboratory research. They are not approved for human consumption, medical treatment, veterinary use, or any in-vivo application.
